ASF-1096 regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Astion's ASF-1096 to treat cutaneous forms of lupus erythematosus. The 0.5% R-salbu...